Subsequently, the remaining prognostic biomarkers from other cancer types were also assessed by OSov, which demonstrated that these genes (SFRP4, NUAK1, MFAP2, PLIN1 and EFNB2) exhibited good performance in predicting ovarian cancer patient outcome (Figure 4B–F). This evidence concerns the gene NUAK1 and ovarian carcinoma.